Replies to post #108 on NorthView Acquisition Corp (NVAC)

[Devolution]

I think upon merger and renaming to Profusa, there will be about 100 million shares.

Since the target is known by the market, and the stock is now trading at a 52 week high of $10.05 (average volume under 11,000 shares per day, often times trades in the single digits or not at all on any given day), then I am convinced the pps will be above $10 per share upon merger ? I mean, why would anyone pay $10 a share now if they didn't believe that this had room to go upward?

The Lumee, when it gets its FDA approval (figure June 2023?) will compete with...or replace...Dexcom's G6 and/or Abbott's Freestyle Libre 2, both of which are big, clumsy, and have to be moved every 2 weeks.

Even my fairly inactive brother-in-law complains that he is always knocking his off, especially at night.

Check out DXCM's 5 year chart, just for sh$ts and giggles.

I know, apples to oranges, but there might be some long term potential there.

[TexasMarvL]

I don't have a paid account on IHUB. I can read your emails, but cannot reply.

[TexasMarvL]

I bought 2 small chunks of shares down here.
Hope to buy more cheap shares in 2 weeks.

[TexasMarvL]

As you can tell from my posts on the AXIM board, I am really pumped about the DED business.

My brain is telling me to trust in Dr Sambursky. He has already built up a diagnostic business. He is still an Eye Doctor for 2 days a month. Verséa gets $10 for every test they sell. Mr Huemoeller said Verséa invested in AXIM.

AXIM will be profitable. Just a matter of time.

Now, I have no idea how long it takes for the share price to reward us. It may be August or September or October or November or December.

However, if the cash-flow keeps increasing then I will keep buying. We will be rewarded at some point.